How to buy Pfizer shares

Easy steps to invest in Pfizer stock in the UK.

Global stock markets soared in response to the news that American pharmaceuticals company Pfizer (PFE) has developed a vaccine, tested on 43,500 people, which it claims is 90% effective.



On the day of the announcement, Pfizer's share price rose 15%, before falling back and closing 7% up on the previous day. Other industries reacted positively to the news, with global economic hopes seemingly pinned on the vaccine.



How to buy shares in Pfizer

  1. Open a brokerage account. Choose from our top broker picks or compare brokers in depth. Then, complete an application.
  2. Fund your account. Add money to your account via bank transfer, debit card or credit card.
  3. Search the platform by ticker symbol. PFE in this case.
  4. Choose an order type. Place a market order or limit order with your preferred number of shares or dollar amount.
  5. Submit the order. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Our top picks for where to buy Pfizer shares

Best for 0% commission stocks
eToro logo
Finder Award
Capital at risk. T&Cs apply.
Copy picks from top traders
Commission-free trades
Fractional shares
Get dividend payments
Best for international trading
IG logo
Capital at risk. T&Cs apply.
4.5% interest on uninvested cash
11,000+ stocks & ETFs
Commission-free investing
Advanced trading tools
Best for fractional shares
XTB logo
Capital at risk. T&Cs apply.
Earn 4.5% on uninvested funds
Commission-free trades
Fractional shares
5,400+ stocks/ETFs

Pfizer stock chart

Use our graph to track the performance of PFE stock over time.

Fees calculator for buying Pfizer shares with popular apps

Both exchange rates and share prices fluctuate in real time, so the costs estimated here should be considered as a guide only. They don't factor in spreads, which can be hard to pin down. Always refer to the platform itself for availability and pricing.

Quantity of shares

100
Platform Finder Score Account fee Min. initial deposit Trade cost Link
eToro logo
9 Excellent
£0 $100 £1,795.98
Go to siteCapital at risk
Freetrade logo
9.1 Excellent
£0 £0 £1,800.26
Go to siteCapital at risk
IG logo
9 Excellent
From £0 £0 £1,795.09
Go to siteCapital at risk
Robinhood logo
8.8 Great
£0 £0 £1,783.15
Go to siteCapital at risk
XTB logo
9.2 Excellent
£0 £0 £1,791.52
Go to siteCapital at risk
Hargreaves Lansdown logo
8.5 Great
£0 (0.45% for funds) £1 £1,812.39
Go to siteCapital at risk

Full comparison of share dealing platforms

These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Alternative ways to invest in Pfizer

Buying shares in just one company is generally considered a riskier bet than investing in a range of investments - AKA a "diversified portfolio". Experts generally recommend holding a mix of investments in specific assets and funds. Funds are ready-made portfolios of multiple companies' shares (potentially including Pfizer), and the idea is that drops in the value of one constituent company's share price might be offset by rises in others.

Pfizer is a major part of the NYSE, so it's included in many global funds and investment trusts, as well as tracker-style exchange traded funds (ETFs).

ETF
5-year performance (to May. '25)
Link
Invesco S&P 500 ETF (SPXP) Invesco S&P 500 ETF icon 97.34% Invest Capital at risk
Xtrackers S&P 500 Swap ETF 1C (XSPX) Xtrackers S&P 500 Swap ETF 1C icon 96.92% Invest Capital at risk
iShares Core S&P 500 ETF USD (Acc) (CSP1) iShares Core S&P 500 ETF USD (Acc) icon 95.53% Invest Capital at risk
HSBC S&P 500 ETF (HSPX) HSBC S&P 500 ETF icon 84.36% Invest Capital at risk

Is it a good time to buy Pfizer stock?

Review technicals and fundamentals to help you determine if now's a good time for you to invest.

Technical analysis

View Pfizer's price performance, share price volatility, historical data and technicals.

The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.

Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.

Historical closes compared with the last close of $24.2

1 week (2025-04-28) 4.99%
1 month (2025-04-05) 5.35%
3 months (2025-02-05) -6.46%
6 months (2024-11-05) -11.55%
1 year (2024-05-05) -12.98%
2 years (2023-05-05) -37.13%
3 years (2022-05-05) -50.65%
5 years (2020-05-05) -37.06%
Promoted
eToro
Invest in Pfizer shares
Finder AwardFree Trades
  • Over 5,500+ stocks from 20 exchanges
  • Free to open an account
  • Commission-free trading

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


Is Pfizer under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Pfizer P/E ratio, PEG ratio and EBITDA.

Pfizer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, Pfizer's shares trade at around 17x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of March 2025 (25.37). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

However, Pfizer's P/E ratio is best considered in relation to those of others within the industry or those of similar companies.

Pfizer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.5659. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Pfizer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

However, it's sensible to consider Pfizer's PEG ratio in relation to those of similar companies.

Pfizer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $23.5 billion (£17.7 billion).

The EBITDA is a measure of Pfizer's overall financial performance and is widely used to measure a its profitability.

To put that into context you can compare it against similar companies.

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.


More guides on Finder

  • Best care home stocks 2025

    Find out the best care home shares along with the pros and cons of investing in this grey-pound-fuelled sector.

  • Mental health stocks: Popular mental health companies to invest in

    Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.

  • Invest in pharmaceutical stocks

    Pharma stocks can be rewarding, but there are risks involved that could impact your profits. Find out the best way to invest in pharma stock.

  • How to buy Curaleaf Holdings shares

    Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.

  • How to buy Eli Lilly and Company shares

    Ever wondered how to buy shares in Eli Lilly and Company? We explain how to invest in Eli Lilly in the UK along with platforms for buying stock.

  • How to buy Aurora Cannabis shares

    Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.

  • How to buy Walgreens Boots Alliance shares

    Ever wondered how to buy shares in Walgreens? We explain how and compare a range of providers that can give you access to many brands, including Walgreens.

  • How to buy Medtronic shares

    Ever wondered how to buy shares in Medtronic? We explain how and compare a range of providers that can give you access to many brands, including Medtronic.

  • How to buy AstraZeneca shares

    Ever wondered how to buy shares in AstraZeneca? We explain how and compare a range of providers that can give you access to many brands, including AstraZeneca.

  • How to buy GSK shares

    Learn more about GSK’s recent performance and where you can buy GSK shares. We also run through a helpful checklist for anyone looking to invest.

Go to site